Wiley循证医学期刊JEBM2022年影响因子为7.3，中科院分区医学2区

根据科睿唯安最新公布的2022 Journal Citation Reports（JCR）数据，由四川大学华西医院和Wiley合作出版的医学期刊Journal of Evidence-Based Medicine（JEBM）2022年影响因子为7.3，位列MEDICINE, GENERAL & INTERNAL学科一区（26/167）；JCI引文指标为0.97。在此衷心感谢各位期刊作者、审稿专家、主编团队和编委的努力与贡献，也感谢广大读者一直以来的关注和支持！

期刊2022影响力指标一览

近期热点文章推荐

Luo, X, Lv, M, Zhang, X, et al. Clinical manifestations of COVID-19: An overview of 102 systematic reviews with evidence mapping. J Evid Based Med. 2022; 15: 201– 215.

Luo, X, Liu, J, Li, Q, et al. Acupuncture for treatment of knee osteoarthritis: A clinical practice guideline. J Evid Based Med. 2023; 1- 9.

Fu, Y, Zhao, J, Han, P, et al. Cost-effectiveness of COVID-19 vaccination: A systematic review. J Evid Based Med. 2023; 1- 14.

Zhang, X, Liang, F, Lau, CT, et al. STandards for Reporting Interventions in Clinical Trials Of Tuina/Massage (STRICTOTM): Extending the CONSORT statement. J Evid Based Med. 2023; 16: 68– 81.

Lee, Y-S, Kim, S-Y, Lee, H, Chae, Y, Lee, MS. ACURATE: A guide for reporting sham controls in trials using acupuncture. J Evid Based Med. 2023; 16: 82– 90.

Pang, W, Yang, F, Zhao, Y, et al. Qingjin Yiqi granules for post-COVID-19 condition: a randomized clinical trial. J Evid Based Med. 2022; 15: 30– 38.

Qin, X, Sun, K, Ao, Y, et al. Traditional Chinese medicine for frozen shoulder: An evidence-based guideline. J Evid Based Med. 2023; 1- 13.

Toubasi, AA, Al-Sayegh, TN, Obaid, YY, Al-Harasis, SM, AlRyalat, SAS. Efficacy and safety of COVID-19 vaccines: A network meta-analysis. J Evid Based Med. 2022; 15: 245– 262.

Dhippayom, T, Saldanha, IJ, Chaiyakunapruk, N, Devine, B. Characterizing health services interventions for evidence syntheses by using the theme, intensity, provider/platform (TIP) framework. J Evid Based Med. 2022; 15: 333– 337.

Liu, D., Chi, Y., Song, P., Zeng, X., Du, L., Chen, Y. and Li, S. Risk factors, clinical manifestation, precaution, and management of monkeypox. J Evid Based Med. 2022；15: 183-186.